|
TMEM218 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.20934381900406E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.947220E-01 |
| Stage1-vs-Stage3 |
1.264540E-03 |
| Stage1-vs-Stage4 |
3.21719995088898E-09 |
| Stage2-vs-Stage3 |
8.413300E-04 |
| Stage2-vs-Stage4 |
1.36100000003303E-06 |
| Stage3-vs-Stage4 |
9.000100E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.84939999875655E-08 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
7.073600E-01 |
| Caucasian-vs-Asian |
5.916600E-01 |
| AfricanAmerican-vs-Asian |
9.475800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.191400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.62809782217255E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.386800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.067600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.274000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.230800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.148000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.610000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.87339962723854E-10 |
| Classical-VS-Follicular |
1.752940E-04 |
| Classical-VS-Other |
4.069600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.1227464230833E-13 |
| Tall-VS-Other |
6.219600E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.982400E-01 |
| Follicular-VS-Normal |
<1E-12 |
| Other-VS-Normal |
6.015200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.75552999999162E-05 |
|
|
